Historique
Rapport
Treatment and prevention of HIV, HCV &HBV among stimulant drugs users. Part 5/5
Titre de série :
Systematic literature review on stimulant use and HIV
Auteur(s) :
ONUDC / UNODC (Office des Nations Unies contre la drogue et le crime / United Nations Office on Drugs and Crime)
Année
2017
Page(s) :
55 p.
Sous-type de document :
Revue de la littérature
Langue(s) :
Anglais
Éditeur(s) :
Vienna : UNODC
Domaine :
Drogues illicites
Discipline :
MAL (Maladies infectieuses / Infectious diseases)
Thésaurus mots-clés
VIH
;
HEPATITE
;
TRAITEMENT
;
INFECTION
;
STIMULANTS
;
PREVENTION
;
CONDUITE A RISQUE
;
REDUCTION DES RISQUES ET DES DOMMAGES
;
PROSTITUTION
;
INTERVENTION
;
ANTIVIRAUX
;
INJECTION
Résumé :
The objective of this review is to carry out a review of published and grey literature on the evidence of injecting and non-injecting stimulant use (particularly crack, cocaine and ATS) and their possible link to HIV, HCV & HBV vulnerability and transmission. To identify:
- The extent of HIV, HCV and HBC infection among stimulant users;
- Specific subgroups of stimulant users at greater risk of HIV, HCV and HBV infection;
- Temporal and geographical patterns of HIV, HCV and HBV infection among stimulant users.
There is no single intervention that will effectively prevent or contain HIV epidemics associated with drug use (Ball, Weiler, Beg, & Doupe, 2005). But comprehensive package of interventions to prevent HIV, HCV and HBV infection among stimulant users are needed. This include developing and implementing specific intervention to reduce sex risk behaviour.
- The extent of HIV, HCV and HBC infection among stimulant users;
- Specific subgroups of stimulant users at greater risk of HIV, HCV and HBV infection;
- Temporal and geographical patterns of HIV, HCV and HBV infection among stimulant users.
There is no single intervention that will effectively prevent or contain HIV epidemics associated with drug use (Ball, Weiler, Beg, & Doupe, 2005). But comprehensive package of interventions to prevent HIV, HCV and HBV infection among stimulant users are needed. This include developing and implementing specific intervention to reduce sex risk behaviour.